These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 28824299
21. A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. Suh CH, Kim KW, Park SH, Shin S, Ahn J, Pyo J, Shinagare AB, Krajewski KM, Ramaiya NH. Eur Radiol; 2018 Jan; 28(1):214-225. PubMed ID: 28726119 [Abstract] [Full Text] [Related]
22. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis. Alamri TM, Cerny M, Al Shaikh M, Billiard JS, Olivié D, Chagnon M, Tang A. Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729 [Abstract] [Full Text] [Related]
23. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. van den Esschert JW, van Gulik TM, Phoa SS. Dig Surg; 2010 Mar; 27(1):46-55. PubMed ID: 20357451 [Abstract] [Full Text] [Related]
29. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Grieser C, Steffen IG, Kramme IB, Bläker H, Kilic E, Perez Fernandez CM, Seehofer D, Schott E, Hamm B, Denecke T. Eur Radiol; 2014 Jun; 24(6):1339-48. PubMed ID: 24658870 [Abstract] [Full Text] [Related]
30. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Auer TA, Fehrenbach U, Grieser C, Penzkofer T, Geisel D, Schmelzle M, Müller T, Bläker H, Seehofer D, Denecke T. Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574 [Abstract] [Full Text] [Related]
33. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study. Nowicki TK, Markiet K, Izycka-Swieszewska E, Dziadziuszko K, Studniarek M, Szurowska E. BMC Gastroenterol; 2018 Jan 15; 18(1):10. PubMed ID: 29334905 [Abstract] [Full Text] [Related]
34. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia. Sannier A, Cazejust J, Lequoy M, Cervera P, Scatton O, Rosmorduc O, Wendum D. Liver Int; 2016 Nov 15; 36(11):1668-1676. PubMed ID: 26969817 [Abstract] [Full Text] [Related]
35. Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors. Gu K, Jeon TY, Yoo SY, Kim JH. Eur Radiol; 2021 Jan 15; 31(1):283-291. PubMed ID: 32797310 [Abstract] [Full Text] [Related]
37. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. Kim HJ, Kim BS, Kim MJ, Kim SH, de Campos RO, Hernandes M, Semelka RC. J Magn Reson Imaging; 2013 Apr 15; 37(4):903-8. PubMed ID: 23065959 [Abstract] [Full Text] [Related]
39. Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis. Pan J, Li W, Gu L, Liu C, Zhang K, Hong G. Eur Radiol; 2022 Nov 15; 32(11):7883-7895. PubMed ID: 35579711 [Abstract] [Full Text] [Related]
40. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma. Kong WT, Wang WP, Huang BJ, Ding H, Mao F, Si Q. Ultrasound Med Biol; 2015 Apr 15; 41(4):944-51. PubMed ID: 25701530 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]